7-difluoromethoxyl-5,4'-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1

July 2014
Oncology Letters;2014, Vol. 8 Issue 1, p295
Academic Journal
7-Difluoromethoxyl-5,4'-di-n-octylgenistein (DFOG) is a novel synthetic genistein analogue that possesses anti-cancer activity in a variety of cancers, including ovarian cancer. The objective of the present study was to investigate whether DFOG inhibits the self-renewal capacity of ovarian cancer stem-like cells (OCSLCs) and to identify its potential mechanism of action. It was found that the sphere-forming cells (SFCs) of the SKOV3 cell line exhibited a self-renewal capacity and high tumorigenicity, indicating that they possessed the properties of ovarian cancer stem cells (OCSCs). It was also shown for the first time that DFOG preferentially inhibited proliferation, self-renewal capacity and expression of stem cell markers [cluster of differentiation (CD)133, CD44 and aldehyde dehydrogenase 1 (ALDH1)] in the SFCs derived from the SKOV3 cells. These effects were accompanied by the downregulation of forkhead box M1 (FOXM1) expression. Overexpression of FOXM1 rescued the DFOG-induced downregulation of FOXM1, CD133, CD44 and ALDH1 protein expression. It also inhibited the self-renewal capacity of the SFCs derived from the SKOV3 cells. Thus, DFOG appears to inhibit the characteristics of OCSLCs by downregulating FOXM1 expression.


Related Articles

  • Effects of Flavonoids from Potamogeton crispus L. on Proliferation, Migration, and Invasion of Human Ovarian Cancer Cells. Du, Yuanda; Feng, Jinhong; Wang, Renqing; Zhang, Haijie; Liu, Jian // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    In order to explore the efficient utilization of plant resources from constructed wetlands, the potential anti-metastatic effects of flavonoids from Potamogeton crispus L. were investigated in human ovarian cancer cells (ES-2). Two major flavonoids, luteolin-3ʹ-O-β--glucopyranoside and...

  • Protein O-glucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells. GANG JIN; ZHIGANG CAO; XILIN SUN; KAI WANG; TAO HUANG; BAOZHONG SHEN // Oncology Letters;2014, Vol. 8 Issue 2, p594 

    Protein O-glucosyltransferase 1 (POGLUT1) is a novel gene that was initially isolated and identified from the bone marrow cells of patients with myelodysplastic syndrome/acute myeloid leukemia. Previous findings have suggested that POGLUT1 promotes the proliferation of U937 human tissue lymphoma...

  • MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A. Biyun Wang; Ziang Yang; Hong Wang; Zhigang Cao; Yannan Zhao; Chengcheng Gong; Lijie Ma; Xiaoxiao Wang; Xichun Hu; She Chen // American Journal of Cancer Research;2015, Vol. 5 Issue 9, p2719 

    MicroRNAs (miRNAs) are deregulated in many types of cancer including breast cancer (BC). miR-320a dysregulation has been associated with different malignancies although its prognostic significance remains unclear. Here, we examined the role of miR-320a in BC and explored the underlying...

  • miRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2. Hong-Bin Zheng; Xiao-Gang Zheng; Bao-Ping Liu // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 11, p20263 

    Objective: To investigate the expression of miRNA-101 in normal and malignant ovarian tissues and cells as well as its impact on the proliferation and invasion of human ovarian cancer H08910 and SKOV3 cell lines. Methods: Real time polymerase chain reaction (RT-PCR) was employed to detect the...

  • Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1. Jie Chen; Fei-Xiang Wu; Hong-Lin Luo; Jun-Jie Liu; Tao Luo; Tao Bai; Le-Qun Li; Xiao-Hui Fan // American Journal of Translational Research;2016, Vol. 8 Issue 11, p4932 

    MicroRNA-22-3p (miR-22-3p) is downregulated in hepatocellular carcinoma (HCC), which contributes to the development and progression of HCC. In this study, berberine treatment upregulated miR-22-3p expression in HepG2 cells. Therefore, we investigated whether berberine suppresses the...

  • Enrichment and characterization of ovarian cancer stem cells and its potential clinical application. Wenxia Wang; Zhenbo Zhang; Yin Zhao; Zeng Yuan; Xingsheng Yang; Beihua Kong; Wenxin Zheng // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 10, p10128 

    The cancer stem cell (CSC) theory proposes that a minor population in tumor cells with specific features, such as self-renewal and reproducible tumor phenotype could contribute to tumor relapse and chemotherapy resistance. Several studies have convincingly documented the existence of ovarian...

  • Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Ketola, K; Hilvo, M; Hyötyläinen, T; Vuoristo, A; Ruskeepää, A-L; Orešič, M; Kallioniemi, O; Iljin, K // British Journal of Cancer;1/3/2012, Vol. 106 Issue 1, p99 

    Background:We have shown that a sodium ionophore monensin inhibits prostate cancer cell growth. A structurally related compound to monensin, salinomycin, was recently identified as a putative cancer stem cell inhibitor.Methods:The growth inhibitory potential of salinomycin was studied in a panel...

  • Catalytically active telomerase holoenzyme is assembled in the dense fibrillar component of the nucleolus during S phase. Lee, Ji; Lee, Yang; Jeong, Sun; Khadka, Prabhat; Roth, Jürgen; Chung, In // Histochemistry & Cell Biology;Feb2014, Vol. 141 Issue 2, p137 

    The maintenance of human telomeres requires the ribonucleoprotein enzyme telomerase, which is composed of telomerase reverse transcriptase (TERT), telomerase RNA component, and several additional proteins for assembly and activity. Telomere elongation by telomerase in human cancer cells involves...

  • Functional features of cancer stem cells in melanoma cell lines. Zimmerer, Rüdiger M.; Korn, Philippe; Demougin, Philippe; Kampmann, Andreas; Kokemüller, Horst; Eckardt, André M.; Gellrich, Nils-Claudius; Tavassol, Frank // Cancer Cell International;2013, Vol. 13 Issue 1, p1 

    Background: Recent evidence suggests a subset of cells within a tumor with "stem-like" characteristics. These cells are able to transplant tumors in immunodeficient hosts. Distinct from non-malignant stem cells, cancer stem cells (CSC) show low proliferative rates, high self-renewing capacity,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics